| Drug Name |
Immunoglobulin (human) |
| Drug ID |
BADD_D01144 |
| Description |
Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. |
| Indications and Usage |
Not Available |
| Marketing Status |
Not Available |
| ATC Code |
J06BA01 |
| DrugBank ID |
DB00028
|
| KEGG ID |
D06458
|
| MeSH ID |
D007136
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
44206-436; 44206-439; 44206-438; 44206-437; 44206-454; 44206-457; 64208-8234; 44206-458; 44206-455; 44206-452; 69800-0250; 44206-451; 44206-456; 64208-8235 |
| Synonyms |
Immunoglobulins | Globulins, Immune | Immunoglobulin | Immune Globulin | Globulin, Immune | Immune Globulins |
